Total raised
—
Last: Seed 2022-07
Stage
Seed
Founded
2017
Headcount
6
HQ
Kefar Sava
Sector
Health Tech & Life Sciences
About
Sol-Del Medical was founded for the development and production of a new innovative Medical PVA soluble delivery system.
Sol-Del is the first to produce a medical grade PVA (Polyvinyl Alcohol) for generic use, allowing insertion of any FDA cleared medicine for topical treatment, OTC creams, ointments or oils. Its advanced topical dressing comprised of multi-cell soluble Medical PVA film, that enables controlled release of an active agent to a skin portion upon contact with an aqueous fluid, such as perspiration, exudate or external applied water-based fluids.
Funding history · 2 rounds · — total
2022-07
Seed
Undisclosed
2021-10
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Sol-Del Medical's primary focus?
- Sol-Del Medical focuses on the development and production of an innovative Medical PVA (Polyvinyl Alcohol) soluble delivery system for topical treatments.
- When was Sol-Del Medical founded?
- Sol-Del Medical was founded in September 2017.
- What is the current status of Sol-Del Medical?
- Sol-Del Medical is currently inactive, having ceased operations in January 2025.
- Where is Sol-Del Medical headquartered?
- Sol-Del Medical is headquartered in Kefar Sava, Israel.
- Has Sol-Del Medical received any funding?
- Yes, Sol-Del Medical received an undisclosed round of funding in October 2021 from CanNegev and a Seed round in July 2022 from OurCrowd.
- What is Sol-Del Medical's product stage?
- Sol-Del Medical's product is in the research and development (R&D) stage.
- How many employees did Sol-Del Medical have?
- Sol-Del Medical had between 1 and 10 employees, with an exact count of 6.
- Does Sol-Del Medical hold any patents?
- Yes, Sol-Del Medical holds one patent.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
drug-deliverypharma-companiespharmaceuticalstopical-treatment